Comparative 12‐week effectiveness and safety outcomes of biologic agents ustekinumab, secukinumab and ixekizumab for the treatment of plaque psoriasis: a real‐world multicenter retrospective study. (8th May 2020) - Georgakopoulos, J.R.; Lam, K.; Sandhu, V.K.; Ighani, A.; Phung, M.; Piguet, V.; Yeung, J.